• Ankylosing Spondylitis Psoriasis, Axial Psoriatic Arthritis Unrelated, Study Says
  • Anti-TNF Therapy Slows Down AS Progression and Bone Loss, Study Says
  • Cosentyx Effectively Lowers Disease Activity in nr-axSpA Patients Treated for 1 Year, Phase 3 Trial Reports
  • AS Patients at Greater Risk of Other Inflammatory Diseases, Taiwanese Study Reports
  • Anger Is a Natural Response to Chronic Illness
  • Heat Therapy Called Moxibustion May Help People with Ankylosing Spondylitis, Short-term Study Finds
  • NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC
  • Depression More Common in People with Ankylosing Spondylitis, Analysis Shows
  • Canceling on Friends: The Good, the Bad, and the Ugly
  • Cosentyx Shows Promise in Managing nr-axSpA Disease Activity, Phase 3 Trial Shows
  • Diffusion-weighted Imaging Useful to Identify Axial Spondyloarthritis
  • Biosimilar to Humira, IBI303, Shows Comparable Efficacy and Safety in Phase 3 Trial in China